Stock Market & Financial Investment News

News Breaks November 13, 2012 08:05 EDT INSM Insmed completes enrollment for Clear-108 Phase 3 study of Arikace Insmed announced that the Company's CLinical Evaluation of Arikace phase 3 European and Canadian registrational study of Arikace for Cystic Fibrosis patients with Pseudomonas aeruginosa lung infections has now enrolled over 300 patients. News For INSM From The Last 14 Days Check below for free stories on INSM the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 10:13 EDT INSM On The Fly: Analyst Initiation Summary Subscribe for More Information 07:40 EDT INSM Insmed initiated with a Buy at Lazard Capital Subscribe for More Information May 14, 2013 08:30 EDT INSM Insmed granted key composition of matter patent allowance for Arikace in EU Subscribe for More Information May 7, 2013 07:43 EDT INSM Insmed reports Q1 EPS (43c), consensus (46c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.